Búsqueda | Portal de Búsqueda de la BVS

1.

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

Botty van den Bruele, Astrid; Ferraro, Emanuela; Sevilimedu, Varadan; Hogan, Molly P; Javed-Tayyab, Sidra; Le, Tiana; Fornier, Monica N; Morrow, Monica; Sacchini, Virgilio.

Breast Cancer Res Treat ; 189(2): 307-315, 2021 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-34263366

2.

A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases.

Xu, Jing; Higgins, Michaela J; Tolaney, Sara M; Come, Steven E; Smith, Matthew R; Fornier, Monica; Mahmood, Umar; Baselga, Jose; Yeap, Beow Y; Chabner, Bruce A; Isakoff, Steven J.

Oncologist ; 25(8): 652-660, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32463152

3.

How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?

Montagna, Giacomo; Sevilimedu, Varadan; Fornier, Monica; Jhaveri, Komal; Morrow, Monica; Pilewskie, Melissa L.

Ann Surg Oncol ; 27(12): 4702-4710, 2020 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-32839900

4.

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Peña, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M; Vuylsteke, Peter; Castaneda, Carlos A; Colleoni, Marco; Santos Borges, Giuliano; Ciruelos, Eva; Fornier, Monica; Boer, Katalin; Bardia, Aditya; Wilson, Timothy R; Stout, Thomas J; Hsu, Jerry Y; Shi, Yi; Piccart, Martine; Gnant, Michael; Baselga, José; de Azambuja, Evandro.

Lancet Oncol ; 20(9): 1226-1238, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31402321

5.

NCCN Task Force Report: Bone Health In Cancer Care.

Gralow, Julie R; Biermann, J Sybil; Farooki, Azeez; Fornier, Monica N; Gagel, Robert F; Kumar, Rashmi; Litsas, Georgia; McKay, Rana; Podoloff, Donald A; Srinivas, Sandy; Van Poznak, Catherine H.

J Natl Compr Canc Netw ; 11 Suppl 3: S1-50; quiz S51, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23997241

6.

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.

Vahdat, Linda T; Thomas, Eva S; Roché, Henri H; Hortobagyi, Gabriel N; Sparano, Joseph A; Yelle, Louise; Fornier, Monica N; Martín, Miguel; Bunnell, Craig A; Mukhopadhyay, Pralay; Peck, Ronald A; Perez, Edith A.

Support Care Cancer ; 20(11): 2661-8, 2012 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22382588

7.

The paradox of triple negative breast cancer: novel approaches to treatment.

Fornier, Monica; Fumoleau, Pierre.

Breast J ; 18(1): 41-51, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-22098334

8.

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Morris, Patrick G; Murphy, Conleth G; Mallam, Divya; Accordino, Melissa; Patil, Sujata; Howard, Jane; Omuro, Antonio; Beal, Kathryn; Seidman, Andrew D; Hudis, Clifford A; Fornier, Monica N.

Breast J ; 18(4): 345-50, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-22607041

9.

Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.

Morris, Patrick G; Fazio, Maurizio; Farooki, Azeez; Estilo, Cherry; Mallam, Divya; Conlin, Alison; Patil, Sujata; Fleisher, Martin; Cremers, Serge; Huryn, Joseph; Hudis, Clifford A; Fornier, Monica N.

J Oral Maxillofac Surg ; 70(12): 2768-75, 2012 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-22330331

10.

Denosumab and fracture risk in women with breast cancer.

Farooki, Azeez; Fornier, Monica.

Lancet ; 386(10008): 2056-2057, 2015 Nov 21.

Artículo en Inglés | MEDLINE | ID: mdl-26700391

11.

Vertebral Fractures After Denosumab Discontinuation in Breast Cancer Survivors: A Single Institution Experience.

Yeung, Michele; Ho, Kaylee; Fornier, Monica N; Farooki, Azeez.

HSS J ; 17(2): 185-191, 2021 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-34421429

12.

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer.

Jhaveri, Komal; Drago, Joshua Z; Shah, Payal Deepak; Wang, Rui; Pareja, Fresia; Ratzon, Fanni; Iasonos, Alexia; Patil, Sujata; Rosen, Neal; Fornier, Monica N; Sklarin, Nancy T; Chandarlapaty, Sarat; Modi, Shanu.

Clin Cancer Res ; 27(14): 3867-3875, 2021 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-33947692

13.

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Lin, Hong; de Stanchina, Elisa; Zhou, Xi Kathy; Hong, Feng; Seidman, Andrew; Fornier, Monica; Xiao, Wei-Lie; Kennelly, Edward J; Wesa, Kathleen; Cassileth, Barrie R; Cunningham-Rundles, Susanna.

Cancer Immunol Immunother ; 59(6): 885-97, 2010 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20140432

14.

HER2-positive breast cancer: beyond trastuzumab.

Murphy, Conleth G; Fornier, Monica.

Oncology (Williston Park) ; 24(5): 410-5, 2010 Apr 30.

Artículo en Inglés | MEDLINE | ID: mdl-20480738

15.

Measuring Tumor Epichaperome Expression Using [¹²⁴I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer.

Jhaveri, Komal L; Dos Anjos, Carlos H; Taldone, Tony; Wang, Rui; Comen, Elizabeth; Fornier, Monica; Bromberg, Jacqueline F; Ma, Weining; Patil, Sujata; Rodina, Anna; Pillarsetty, Nagavarakishore; Duggan, Susan; Khoshi, Sarhe; Kadija, Nathan; Chiosis, Gabriela; Dunphy, Mark P; Modi, Shanu.

JCO Precis Oncol ; 42020.

Artículo en Inglés | MEDLINE | ID: mdl-33283132

16.

First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.

Krebs, Simone; Veach, Darren R; Carter, Lukas M; Grkovski, Milan; Fornier, Monica; Mauro, Michael J; Voss, Martin H; Danila, Daniel C; Burnazi, Eva; Null, Manda; Staton, Kevin; Pressl, Christina; Beattie, Bradley J; Zanzonico, Pat; Weber, Wolfgang A; Lyashchenko, Serge K; Lewis, Jason S; Larson, Steven M; Dunphy, Mark P S.

J Nucl Med ; 61(11): 1580-1587, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32169913

17.

A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.

Sugarman, Steven; Wasserheit, Carolyn; Hodgman, Elizabeth; Coglianese, Maryellen; D'Alassandro, Anne; Fornier, Monica; Fournier, Monica; Troso-Sandoval, Tiffany; D'Andrea, Gabriella; Drullinsky, Pamela; Lake, Diana; George, Roshini; Mills, Nancy; Moynahan, Maryellen; Smith, Joyce; Panageas, Katherine; Norton, Larry; Hudis, Clifford.

Breast Cancer Res Treat ; 115(3): 609-12, 2009 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18751888

18.

Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity.

Nisticò, Cecilia; Bria, Emilio; Vaccaro, Vanja; Cuppone, Federica; Fornier, Monica; Sperduti, Isabella; Carpino, Armando; Izzo, Fiorentino; Tropea, Francesco; Cognetti, Francesco; Terzoli, Edmondo.

Anticancer Drugs ; 20(2): 109-14, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-19209027

19.

Microtubule active agents: beyond the taxane frontier.

Morris, Patrick G; Fornier, Monica N.

Clin Cancer Res ; 14(22): 7167-72, 2008 Nov 15.

Artículo en Inglés | MEDLINE | ID: mdl-19010832

20.

Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.